Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124231663 | 12423166 | 3 | F | 201605 | 20160616 | 20160601 | 20160701 | EXP | BR-PFIZER INC-2016262265 | PFIZER | 89.00 | YR | F | Y | 0.00000 | 20160701 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124231663 | 12423166 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 DROP IN EACH EYE, AT NIGHT | Y | U | N00717 | 20597 | 2 | GTT | EYE DROPS, SOLUTION | QD | |||
| 124231663 | 12423166 | 2 | SS | XALATAN | LATANOPROST | 1 | Ophthalmic | UNK | Y | U | M05274 | 20597 | EYE DROPS, SOLUTION | ||||||
| 124231663 | 12423166 | 3 | SS | XALATAN | LATANOPROST | 1 | UNK | Y | U | MO0717 | 20597 | EYE DROPS, SOLUTION | |||||||
| 124231663 | 12423166 | 4 | C | AZOPT | BRINZOLAMIDE | 1 | UNK | 0 | |||||||||||
| 124231663 | 12423166 | 5 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 124231663 | 12423166 | 6 | C | MAREVAN | WARFARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 124231663 | 12423166 | 7 | C | LEXOTAN | BROMAZEPAM | 1 | 0 | ||||||||||||
| 124231663 | 12423166 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 124231663 | 12423166 | 9 | C | DAFLON /01026201/ | DIOSMINHESPERIDIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124231663 | 12423166 | 1 | Glaucoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124231663 | 12423166 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124231663 | 12423166 | Blood glucose increased | |
| 124231663 | 12423166 | Blood pressure increased | |
| 124231663 | 12423166 | Eye irritation | |
| 124231663 | 12423166 | Eye pruritus | |
| 124231663 | 12423166 | Nervousness | |
| 124231663 | 12423166 | Ocular hyperaemia | |
| 124231663 | 12423166 | Product expiration date issue | |
| 124231663 | 12423166 | Vision blurred | |
| 124231663 | 12423166 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124231663 | 12423166 | 1 | 2013 | 20160514 | 0 | |
| 124231663 | 12423166 | 2 | 20160514 | 0 | ||
| 124231663 | 12423166 | 4 | 2013 | 0 | ||
| 124231663 | 12423166 | 6 | 2013 | 0 | ||
| 124231663 | 12423166 | 9 | 2013 | 0 |